



























Activation of sirtuins has been proved to be positive in 
age-related diseases [1-5]. However, the role of sirtuin 
activation in acute diseases, such as inflammatory 
processes, has not been clearly defined. Stress-activated 
protein kinases (SAPKs) are essential components for 
intracellular signalling networks that serve to respond and 
adapt to extracellular changes. Stress-activated protein 
kinases play a key role in signal transduction to 
extracellular insults and have been involved in numerous 
diseases, including inflammatory processes [6-8]. 
Exposure of yeast to high osmolarity results in the 
transient activation of p38-related SAPK, Hog1, the yeast 
homologue of the p38 SAPK [9,10]. The transient 
activation of the SAPK serves to control many aspects of 
the cell physiology ranging from control of metabolism, 
cell cycle progression and gene expression which are 
essential for cellular adaptation to stress [11-15]. Despite 
the essential role of Hog1 in cell survival upon stress, it 
has been known for a long time that sustained activation 
of the SAPK was deleterious for cell growth as it has 
been shown by other MAPKs [16-18]. Therefore, the 
dynamics of Hog1 activation are critical for cell fate 
determination. However, the mechanism by which Hog1 





























The study by Vendrell et al shows that inhibition of cell 
growth by sustained activation of Hog1 is caused by the 
induction of apoptosis-like cell death in yeast. 
Specifically, activation of the Hog1 SAPK inhibits 
mitochondrial respiration that leads to an increase in 
ROS levels (Figure 1). This increase in ROS levels 
correlates with a decrease in mitochondrial respiration 
and it is prevented when cells are grown in the absence 
of oxygen. Therefore, the increase in ROS production 
seems to be caused by electron transport inhibition. 
 
Several apoptotic makers can be detected upon Hog1 
activation; such as an increase in SubG1 cells, DNA 
aggregation, TUNEL assay positive cells and 
metascaspase activation. Remarkably, deletion of genes 
encoding apoptosis mediators, such as the Omi yeast 
homologue (NMA111) or, to a lesser extent, the YCA1 
caspase prevented Hog1-induced cell death. Taken 
together, Hog1-induced cell death is likely to be caused 
by apoptosis.  
 
Unexpectedly, mutations in the E3 ubiquitin ligase 
CDC4, as well as the core components of the SCF 
complex (SKP1 and CDC53) partially suppressed 
Hog1-induced cell death. SCF mutations resulted in a 
reduced Msn2/Msn4 degradation that led to an increase 



















in  age‐related  diseases  and  the  conserved  role  of  SAPKs  open  the  possibility  of  a  novel  role  for  sirtuins  in  cell  fate
determination in eukaryotic cells. 
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deacetylase, is under the control of Msn2/Msn4 
transcription factors [19]. The mutations on SCFcdc4 
resulted in an increased association of Msn2/4 at the 
PNC1 promoter and to an increased PNC1 expression. 
The relevance of Msn2-mediated PNC1 expression 
and the role of Sir2 in cell survival are illustrated by 
the fact that deletion of MSN2/4, PNC1 or SIR2 
resulted in cells unable to suppress the apoptosis 
caused by sustained activation of Hog1. In contrast, 
over-expression of MSN2, PNC1 or SIR2 prevented 
Hog1-induced cell death. Therefore, Sir2 activation is 
important to prevent SAPK-induced apoptotic cell 
death (Figure 1). 
 
The mechanism by which Sir2 prevents apoptosis in 






































vation does not alter cellular respiration upon stress, it 
strongly reduces ROS production and hence, it is likely 
that this reduction in ROS permits cell survival upon 
Hog1 activation.  
 
Activation of SAPK signalling is essential for cell 
adaptation to stress. Strikingly, sustained activation of the 
pathway unravels a more-complex scenario. Therefore, 
although a decrease in mitochondrial respiration might be 
important for adaptation to stress, an extended reduction 
of respiration leads to excessive ROS formation. To 
counteract cell damage, Hog1 seems to engage a 
protective program by inducing PNC1 gene expression, 
which concomitantly activates Sir2 to balance excessive 
ROS accumulation. Therefore, cell fate is dictated by the 
balance between ROS induced by Hog1 SAPK and the 








































































MAPKs, apoptosis and mitochondrial function 
 
Apoptosis is caused by a variety of factors, such as 
oxidative stress [20]. Induction of apoptosis in response 
to MAPK activation has been described in several cell 
types and organisms [17, 21-24]. The p38 MAPK is 
activated by several stresses as well as oxidative stress 
[25, 26]. However, it is not known whether p38 is able to 
cause oxidative stress by altering mitochondrial function. 
Data from yeast suggests that, directly or indirectly, 
MAPKs can modulate mitochondrial respiration and 
ROS production. Then, it would be interesting to test 
whether, once p38 is activated, the MAPK regulates 
mitochondrial activity and ROS levels. A putative 
scenario would be that an increase of ROS could serve to 
create a positive feedback loop to sustain MAPK 
activation in the presence of stress.  
 
The mechanism by which Hog1 regulates mitochondrial 
respiration and ROS levels remains unknown. It cannot 
be excluded that regulation of metabolism could lead to 
an altered TCA cycle and/or mitochondrial respiration. 
Therefore, the characterization of this phenomenon will 





























with the mitochondria: regulating mitochondria 
biogenesis, respiratory chain formation or respiratory 
chain activity. This would help to know whether the 
effect of Hog1 MAPK could be conserved in higher 
eukaryotes. 
 
Sirtuins, apoptosis and lifespan extension 
 
The effect of sirtuins in apoptotic cell death is not clear. 
Depending on expression of a specific sirtuin, the cell 
type and the stimuli, sirtuins prevent or induce apoptosis 
[27-29]. Moreover, it is not clear whether the effect of 
sirtuin overexpression to extend lifespan in higher 
eukaryotes, such as worms and flies [30]. In yeast, Sir2 
prevents apoptosis mediated by Hog1. There have been 
several molecular alterations associated to replicative 
ageing, such as the accumulation of extrachromosomal 
ribosomal DNA circles (ERCs), the assimetrically 
distribution of oxidatively damaged proteins and/or 
altered mitochondria that seems to be, at least partially 
controlled by Sir2 [31-35]. However, the relationship of 
these phenomena and the induction of cell death is not 
yet defined. In yeast, Sir2 effect upon Hog1 activation  
Net1 (an anchor for Sir2 to rDNA) but not on Sir4 or  
HM loci [31, 36, 37]. This suggests that the role of Sir2 
in Hog1-mediated cell death might be associated to ERCs 
in contrast to other Sir2 functions.  
Figure  2.  Scheme  of  Hog1‐induced  Msn2/Msn4  dependent  gene  expression  upon
SCF
cdc4 
regulation.  Activation  of  Hog1  SAPK  induces  the  activation  of  Msn2/Msn4‐
dependent  genes,  such  as  PNC1.The  E3 
SCFcdc4  ubiquitin  ligase  ubiquitylates  the
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seems to show that Sir2 might not be responsible of 
lifespan extension albeit important for health in ageing 
processes [38]. Remarkably, overexpression of Sir2 
prevents apoptosis in yeast. It is worth noting that this 
preventive effect is only observed upon strong 
overexpression of Sir2. Two-fold overexpression of Sir2 
did not show a significant effect on preventing apoptosis 
upon Hog1 sustained activation. A recent study in mice 
with moderately overexpression of Sirt1 reports 
prevention in age-related diseases, but without effects in 
lifespan [5]. Therefore, the degree of Sir2 expression 
might be critical to affect some age-related effects that 
might be associated to the degree of oxidative stress in 
the cell. 
 
Activation and regulation of apoptosis in an 
unicellular model 
 
Apoptosis in yeast is a controversial issue. The benefit 
that could generate programmed cell death in a 
unicellular organism has been deeply discussed [39]. It is 
thought that the benefit of programmed cell death in 
yeast might be associated to a population rather to an 
individual [40]. Upon stress, the older or damaged 
individuals could enter into programmed cell death to 
allow other cells, genetically identical to them, increase 
their resources to survive.  
 
The determination of cell fate upon stress could result of 
the balance between cell survival and cell death. Once 
cells are exposed to a stress, Hog1 SAPK is activated and 
cells enter into an alarm state. Upon a mild stress, Hog1 
SAPK is active for a short period of time. Then, Hog1-
induced sirtuin activation might be sufficient to prevent 
ROS accumulation, and the whole population survives. 
However, upon severe stress or sustained activation of 
the SAPK, longer activation of the MAPK Hog1 induces 
an increase on ROS production beyond a certain 
threshold. It is likely then that the preventive effect of 
sirtuin activation might not be sufficient to compensate 
ROS levels and certain cells of the population would 
undergo apoptosis and provide more resources to the 
younger cells to adapt and survive to a severe stress. The 
fact that both pro and anti-apoptotic pathways are 
controlled by the same protein, Hog1, emphasize the 
importance of the balance between the two responses that 




Vendrell and collaborators have unraveled the ability of 
Sir2 to prevent ROS formation and cell death upon 
MAPK activation in yeast. However, the mechanism by 
which Sir2 prevents ROS formation remains unclear. It 
would be interesting in the field of sirtuins to define how 
Sir2 is able to reduce ROS levels and decipher whether 
Sir2 is modulating mitochondrial activity per se or it is 
inducing antioxidant defence mechanisms.  
 
It is likely that, as occurs in yeast, the balance in sirtuin 
activation determines cell fate in higher eukaryotes cells. 
Recent data show that two-fold overexpression of Sir2 in 
flies and worms did not extend lifespan at least as much 
as it was reported before [41-45]. In fact, other previous 
works showed that, also in yeast, two-fold Sir2 
overexpression does not extend lifespan in some 
backgrounds [46]. Data provided by Vendrell et al show 
the importance of sirtuin dose and activation in 
preventing ROS accumulation and apoptosis in yeast. 
Since only dramatic overexpression of Sir2 is able to 
prevent apoptosis in yeast, further studies with stronger 
sirtuin overexpression might uncover the role of sirtuins 
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